Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

FBRX – Forte Biosciences Inc

Forte Biosciences, Inc.
FBRX
$14.41
Name : Forte Biosciences, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $179,157,424.00
EPSttm : -3.68
finviz dynamic chart for FBRX
Forte Biosciences, Inc.
$14.41
1.26%
$0.18

Float Short %

1.06

Margin Of Safety %

Put/Call OI Ratio

75

EPS Next Q Diff

-0.08

EPS Last/This Y

7.74

EPS This/Next Y

1.11

Price

14.18

Target Price

52.25

Analyst Recom

1

Performance Q

14.02

Relative Volume

0.69

Beta

3

Ticker: FBRX




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-09-08FBRX10.99112.00999.99226
2025-09-09FBRX11.07112.00999.99226
2025-09-10FBRX10.94112.00999.99226
2025-09-11FBRX10.48112.00999.99226
2025-09-12FBRX10.52N/AN/A0
2025-09-15FBRX11.43112.500.00227
2025-09-16FBRX12.3175.00999.99228
2025-09-17FBRX11.9675.333333333333999.99229
2025-09-18FBRX13.0775.33999.99229
2025-09-19FBRX13.6575.33999.99229
2025-09-22FBRX14.851.00999.994
2025-09-23FBRX15.981.00999.994
2025-09-24FBRX14.9458.50999.99119
2025-09-25FBRX14.1269.50999.99141
2025-09-26FBRX13.6169.50999.99141
2025-09-29FBRX14.5169.50999.99141
2025-09-30FBRX14.969.50999.99141
2025-10-01FBRX14.5169.50999.99141
2025-10-02FBRX13.4369.50999.99141
2025-10-03FBRX15.4869.50999.99141
2025-10-06FBRX14.475.000.10152
2025-10-07FBRX14.1775.000.10152
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-09-08FBRX11.1376.5- -4.43
2025-09-09FBRX10.9176.5- -4.43
2025-09-10FBRX10.9376.5- -4.43
2025-09-11FBRX10.4676.5- -4.43
2025-09-12FBRX10.5676.5- -4.43
2025-09-15FBRX11.4876.5- -4.43
2025-09-16FBRX12.3376.5- -4.43
2025-09-17FBRX11.9376.5- -4.43
2025-09-18FBRX13.2176.5- -4.43
2025-09-19FBRX13.6476.5- -4.43
2025-09-22FBRX14.7876.5- -4.43
2025-09-23FBRX15.9876.5- -4.43
2025-09-24FBRX14.9976.5- -4.43
2025-09-25FBRX14.2576.5- -4.43
2025-09-26FBRX13.8476.5- -4.43
2025-09-29FBRX14.4076.5- -4.43
2025-09-30FBRX14.9476.5- -4.43
2025-10-01FBRX14.5076.5- -4.43
2025-10-02FBRX13.2376.5- -4.43
2025-10-03FBRX15.4876.5- -4.43
2025-10-06FBRX14.6076.5- -4.43
2025-10-07FBRX14.1876.5- -4.43
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-09-08FBRX0.00360.080.96
2025-09-09FBRX0.00360.080.96
2025-09-10FBRX0.00360.080.96
2025-09-11FBRX0.00360.080.93
2025-09-12FBRX0.00360.080.93
2025-09-15FBRX0.00182.920.93
2025-09-16FBRX0.00182.920.93
2025-09-17FBRX0.00182.920.93
2025-09-18FBRX0.00182.920.93
2025-09-19FBRX0.00182.920.93
2025-09-22FBRX0.00182.920.93
2025-09-23FBRX0.00182.920.93
2025-09-24FBRX0.00182.920.93
2025-09-25FBRX0.00182.921.06
2025-09-26FBRX0.00182.921.06
2025-09-29FBRX0.00182.921.06
2025-09-30FBRX0.00182.921.06
2025-10-01FBRX0.00182.921.06
2025-10-02FBRX0.00182.921.06
2025-10-03FBRX0.00182.921.06
2025-10-06FBRX0.0042.231.06
2025-10-07FBRX0.0042.231.06
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

-0.96

Avg. EPS Est. Current Quarter

-1.07

Avg. EPS Est. Next Quarter

-1.04

Insider Transactions

Institutional Transactions

42.23

Beta

3

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

9

Growth Score

19

Sentiment Score

68

Actual DrawDown %

98.8

Max Drawdown 5-Year %

-99.6

Target Price

52.25

P/E

Forward P/E

PEG

P/S

P/B

1.77

P/Free Cash Flow

EPS

-7.99

Average EPS Est. Cur. Y​

-4.43

EPS Next Y. (Est.)

-3.33

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

0.69

Return on Equity vs Sector %

-68.2

Return on Equity vs Industry %

-54.5

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.05

EBIT Estimation

Forte Biosciences, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 17
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.
stock quote shares FBRX – Forte Biosciences Inc Stock Price stock today
news today FBRX – Forte Biosciences Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch FBRX – Forte Biosciences Inc yahoo finance google finance
stock history FBRX – Forte Biosciences Inc invest stock market
stock prices FBRX premarket after hours
ticker FBRX fair value insiders trading